首页> British journal of haematology> A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.

A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Guido,Finazzi

第一单位： Haematology, Ospedale Papa Giovanni XXIII, Bergamo, Italy.

作者： Guido,Finazzi ^[1] ; Alessandro M,Vannucchi ^[2] ; Vincenzo,Martinelli ^[3] ; Marco,Ruggeri ^[4] ; Francesco,Nobile ^[5] ; Giorgina,Specchia ^[6] ; Enrico Maria,Pogliani ^[7] ; Odoardo Maria,Olimpieri ^[8] ; Giuseppe,Fioritoni ^[9] ; Caterina,Musolino ^[10] ; Daniela,Cilloni ^[11] ; Piera,Sivera ^[12] ; Giovanni,Barosi ^[13] ; Maria Chiara,Finazzi ^[1] ; Silvia Di,Tollo ^[14] ; Tim,Demuth ^[14] ; Tiziano,Barbui ^[1] ; Alessandro,Rambaldi ^[1]

作者单位： Haematology, Ospedale Papa Giovanni XXIII, Bergamo, Italy. ^[1] Haematology, University of Florence, A.O.U. Careggi, Florence, Italy. ^[2] Haematology Unit, A.O.U. "Federico II", Naples, Italy. ^[3] Department of Cell Therapy and Haematology, San Bortolo Hospital, Vicenza, Italy. ^[4] Onco-haematology Department, A.O. "Bianchi-Melacrino-Morelli, Reggio Calabria, Italy. ^[5] Haematology Unit, A.O.U. Policlinico Consorziale, Bari, Italy. ^[6] Clinical Haematology, New Hospital San.Gerardo, University of Milano Bicocca, Monza, Italy. ^[7] Haematology Department, "Campus Bio-Medico" University, Rome, Italy. ^[8] Clinical Haematology Unit, AUSL "Spirito Santo", Pescara, Italy. ^[9] UOC Haematology, Azienda Ospedaliera Universitaria, Messina, Italy. ^[10] Internal Medicine 2, AOU San Luigi Gonzaga, Orbassano, Italy. ^[11] SCU Haematology, A.O. "Ordine Mauriziano" Umberto I, Turin, Italy. ^[12] Centre for the Study of Myelofibrosis, IRCCS Policlinico S.Matteo Foundation, Pavia, Italy. ^[13] Clinical R&D Department, Italfarmaco S.p.A., Cinisello Balsamo, Italy. ^[14]